Extracellular vesicles (EVs), including exosomes and microvesicles, derived from
mesenchymal stem/stromal cells (MSCs) exert similar effects as their parental cells, and are …

Background The therapeutic potential of mesenchymal stromal cells (MSCs) may be largely
mediated by paracrine factors contained in microvesicles (MV) released from intracellular …

Stem cell–derived small extracellular vesicles (sEVs) promote angiogenesis after
myocardial infarction (MI). However, the components of sEVs that contribute to these effects …

Introduction Administration of mesenchymal stem cells (MSCs) represents a promising
treatment option for patients suffering from immunological and degenerative disorders …

Mesenchymal stem cell transplantation (MSCT) has been used to treat human diseases, but
the detailed mechanisms underlying its success are not fully understood. Here we show that …

Osteoarthritis (OA) is the most common form of degenerative arthritis, mainly characterized
by the degradation of articular cartilage and associated with subchondral bone lesions …

Mesenchymal stromal cell (MSC) therapies have been pursued for a broad spectrum of
indications but mixed reports on clinical efficacy have given rise to some degree of …

The therapeutic potential of mesenchymal stromal cells (MSCs) is evident by the number of
new and ongoing trials targeting an impressive variety of conditions. In bone and cartilage …

Background Acute myocardial infarction is a major health problem and is the leading cause
of death worldwide. Myocardial apoptosis induced by myocardial infarction injury is involved …

Alzheimer's disease (AD) is the most common type of dementia affecting regions of the
central nervous system that exhibit synaptic plasticity and are involved in higher brain …